In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

For those who smoke, this long-term habit can damage parts of your eye, contributing to serious conditions such as macular ...

Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.

The following is a summary of “High Density Lipoproteins Associate with Age-Related Macular Degeneration in the All of Us Research Program,” published in the January 2025 issue of Ophthalmology by ...

Clearside Biomedical (CLSD) announces that two subgroup analyses were presented from the ODYSSEY Phase 2b clinical trial at the Angiogenesis, ...

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

OliX and Eli Lilly announced a global licensing agreement, focusing on the development and commercialization of OliX’s ...

Metro spoke to nine couples who have been together for decades — from 15 years to 75 — to share their biggest relationship ...